SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-109319
Filing Date
2016-06-22
Accepted
2016-06-22 17:08:13
Documents
15
Period of Report
2016-06-16
Items
Item 1.03: Bankruptcy or Receivership
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v442715_8k.htm 8-K 49084
2 EXHIBIT 2.1 v442715_ex2-1.htm EX-2.1 725649
3 EXHIBIT 99.1 v442715_ex99-1.htm EX-99.1 10498
4 GRAPHIC ex99-1pg01.jpg GRAPHIC 114456
5 GRAPHIC ex99-1pg02.jpg GRAPHIC 127652
6 GRAPHIC ex99-1pg03.jpg GRAPHIC 69049
7 GRAPHIC ex99-1pg04.jpg GRAPHIC 137886
8 GRAPHIC ex99-1pg05.jpg GRAPHIC 116740
9 GRAPHIC ex99-1pg06.jpg GRAPHIC 109588
10 GRAPHIC ex99-1pg07.jpg GRAPHIC 72064
11 GRAPHIC ex99-1pg08.jpg GRAPHIC 172056
12 GRAPHIC ex99-1pg09.jpg GRAPHIC 135224
13 GRAPHIC ex99-1pg10.jpg GRAPHIC 119904
14 GRAPHIC ex99-1pg11.jpg GRAPHIC 99631
15 GRAPHIC ex99-1pg12.jpg GRAPHIC 106628
  Complete submission text file 0001144204-16-109319.txt   2687437
Mailing Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878
Business Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35798 | Film No.: 161727129
SIC: 2834 Pharmaceutical Preparations